Hrt Financial LP Ani Pharmaceuticals Inc Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$48.72 - $65.43 $1.4 Million - $1.87 Million	28,634 New	28,634 $1.58 Million
Q1 2023 May 12, 2023	BUY	$37.61 - $45.72 $347,704 - $422,681	9,245 New	9,245 $367,000
Q4 2021 Feb 14, 2022	SELL	$32.97 - $56.85 $265,870 - $458,438	-8,064 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.48 - $35.99 $213,534 - $290,223	8,064 New	8,064 $264,000

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.